Categories Earnings, Health Care

Bio-Path Holdings, Inc. (NASDAQ: BPTH): Q3 2019 Earnings Snapshot

— Bio-Path Holdings, Inc. (NASDAQ: BPTH) reported a net loss of $2.2 million or $0.78 share for the third quarter of 2019, vs. $0.74 per share loss expected.

— Research and development expenses decreased to $1.4 million from $2.3 million last year

— General and administrative expenses were $0.9 million during the three-month period, up 29% from last year

— Recorded cash of $15.4 million as of September 30, 2019, compared to $1.0 million at December 31, 2018

— Net cash used in operating activities was $6.1 million during the nine-month period ended September, compared to $4.8 million last year

— Recently, appointed Martina Molsbergen, chief executive officer of C14 Consulting, to the board of directors of Bio-Path

Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text

Most Popular

Kroger (KR) looks set to start 2023 with new vigor. Is the stock a buy?

The retail environment has witnessed many changes in customers’ shopping behavior lately, especially after the COVID outbreak. With inflation putting pressure on personal finances, there appears to be a new

Dollar General (DG): Five takeaways from the discount store’s Q3 earnings report

Shares of Dollar General Corporation (NYSE: DG) were up over 2% on Friday, a day after the company delivered mixed results for the third quarter of 2022 and lowered its

Salesforce stock hit by weak guidance, co-CEO’s exit. What next?

For technology stocks, 2022 has been a challenging year, with companies losing significant market value amid prolonged stock selloff. In that respect, Salesforce, Inc. (NYSE: CRM) is among the worst-affected

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top